U.S. Marine and Shipping Stock News

Earlier in 2026, Better Home & Finance and Coinbase launched a Fannie Mae-approved mortgage product that lets borrowers pledge Bitcoin or USDC as collateral for conforming home loans without selling their crypto holdings. This first-ever integration of digital assets into the Fannie Mae framework could widen access to homeownership for crypto-focused, typically younger borrowers while testing how traditional housing finance handles crypto-related risks. We’ll now examine how Fannie Mae’s...

Sigma Lithium (NasdaqCM:SGML) just posted its FY 2025 third quarter scorecard with revenue of US$28.5 million and a basic EPS loss of US$0.10, alongside net income excluding extra items of a US$11.6 million loss. The company has seen quarterly revenue move between US$16.9 million and US$47.7 million over the past three reported quarters, with basic EPS ranging from a profit of US$0.04 to losses of US$0.17. Trailing twelve month EPS stands at a loss of US$0.30 on revenue of US$139.0 million...

IonQ (NYSE:IONQ) has entered a definitive agreement to acquire SkyWater Technology in a deal valued at US$1.8b. The transaction deepens IonQ’s control over its quantum hardware supply chain by bringing a semiconductor and foundry partner in house. This move is positioned to support IonQ’s efforts toward commercially viable, fault tolerant quantum computing. For readers tracking quantum computing, IonQ is one of the better known pure play names, focused on building trapped ion quantum...

If you are wondering whether nLIGHT's share price still reflects its underlying value, it helps to step back from the excitement and look closely at what the numbers actually say. The stock trades at US$53.98 after a 40.7% return year to date, which comes on top of a very large 1 year gain and a 438.7% return over 3 years, despite a recent 22.8% 7 day pullback and a modest 3.9% 30 day decline. Recent coverage has focused on nLIGHT's position in high performance laser technology and its role...

Earlier in March 2026, Casella Waste Systems, Inc. appointed Christopher A. Rains as Senior Vice President and Chief Revenue Officer, adding a leader with more than two decades of commercial, operational, and customer-focused experience across major waste management and industrial companies. Rains’ combination of industry depth, Lean Six Sigma Black Belt training, and proven work on complex organizational transformations introduces fresh commercial leadership that could influence how Casella...

Papa John’s International recently launched Oven-Toasted Sandwiches on toasted ciabatta-style bread, featuring high-quality meats, white American cheese, new signature sauces, and bundle pricing starting at US$7.99. This move extends Papa John’s beyond its traditional pizza focus, using premium, garlic-sauce-brushed sandwiches to try to refresh demand amid weak same-store sales and higher operating costs. Next, we’ll consider how this push into indulgent, garlic-brushed Oven-Toasted...

Apogee Therapeutics recently reported positive 52-week Phase 2 APEX trial data for its lead anti-IL-13 antibody zumilokibart in moderate-to-severe atopic dermatitis, alongside completing a follow-on common stock offering of about US$403,000,000 at US$70 per share. The maintenance data suggest zumilokibart may offer durable disease control with 3- or 6-month dosing intervals, a dosing schedule that could meaningfully differentiate it from existing atopic dermatitis treatments if later-stage...

Middleby stock performance and recent context Middleby (MIDD) has been under pressure recently, with the share price showing negative returns over the past week, month and past 3 months, prompting investors to reassess how its current valuation lines up with the underlying business. See our latest analysis for Middleby. The recent 24.68% 30 day share price decline, alongside a 16.31% 1 year total shareholder return decline, suggests momentum has faded and investors are reassessing Middleby at...

In March 2026, Protagonist Therapeutics reported one-year Phase 3 data for ICOTYDE (icotrokinra) in moderate to severe plaque psoriasis, showing sustained skin clearance and a favorable safety profile as the first oral IL-23 receptor–targeted peptide. The data, including adolescent results through Week 52, underline ICOTYDE’s potential as a once-daily pill alternative to injectable treatments and highlight the company’s peptide discovery platform. We’ll now look at how ICOTYDE’s...

Event context and recent price performance Biglari Holdings (BH.A) recently caught investor attention after a 3% move in the latest session, contrasting with a decline of about 17% over the past month and a smaller pullback over the past 3 months. See our latest analysis for Biglari Holdings. That recent 3% daily share price move sits against a weaker short term trend, with a 30 day share price return of about a 17% decline. However, the 1 year total shareholder return of 50.73% and 5 year...

Mother’s Day collaboration puts Bath & Body Works stock in focus Bath & Body Works (BBWI) is drawing fresh investor attention after unveiling a Vera Bradley collaboration for Mother’s Day, a limited-edition collection that spans body care, home fragrance, decor and accessories. See our latest analysis for Bath & Body Works. That Mother’s Day launch lands at a time when the 1-day share price return of 11.13% stands in contrast to a 30-day share price return decline of 17.97% and a 1-year total...

In the first quarter ended February 28, 2026, KB Home reported lower sales and net income year over year, while also completing a US$150 million share repurchase totaling 2,397,196 shares under its October 2025 authorization. At the same time, management issued revenue guidance for the second quarter and full year 2026 that frames housing revenues within a relatively tight range, underscoring a cautious demand outlook despite continued capital returns. Next, we will examine how KB Home’s...

At the March 12, 2026 BofA Securities Information & Business Services Conference, First Advantage Corporation highlighted 17% fourth-quarter revenue growth, a transition toward capital risk management solutions, and board approval of a US$100,000,000 share repurchase program. The company’s emphasis on expanding beyond background screening into a broader capital risk management platform, supported by about 97% client retention, underlines management’s confidence in scaling the business...

Relay Therapeutics (RLAY) is back in focus after releasing new Phase 1/2 ReDiscover trial data for zovegalisib plus fulvestrant in PI3Ka-mutated, HR+/HER2- metastatic breast cancer, supporting its selected Phase 3 dosing regimen. See our latest analysis for Relay Therapeutics. The latest trial update comes after a sharp move in the stock, with a 1 day share price return of negative 5.14% and a 30 day share price return of negative 6.43%. However, a 1 year total shareholder return of 266.41%...

Recently, Globant and PharmaMar announced a collaboration to apply Globant Enterprise AI in accelerating cancer drug discovery, while Globant and Adyen formalized a global partnership making Globant a lead integration partner for Adyen’s payments platform. Together, these alliances show how Globant is embedding its AI and integration capabilities at the core of critical workflows in both healthcare R&D and global payments infrastructure. Now we’ll examine how Globant’s AI-powered PharmaMar...

With no single headline event driving Allegion (ALLE) into focus, investors are instead looking at the stock's recent performance and fundamentals, including its US$4,067.3m in revenue and US$643.8m in net income. See our latest analysis for Allegion. Allegion’s recent share price performance has been soft, with a 1-month share price return of 10.33% and a year to date share price return of 10.2%. The 1-year total shareholder return sits at 12.27%, which hints at longer term holders faring...

Schneider National (SNDR) recently reported quarterly results, with revenue up 4.5% year on year but below analyst expectations, and full-year EPS guidance also under forecasts. This combination has coincided with a 13.5% decline in the share price. See our latest analysis for Schneider National. At a share price of $25.44, Schneider National’s 30 day share price return of 10.36% and 90 day share price return of 5.25% sit against a 1 year total shareholder return of 13.07%. This indicates...

Global Partners (GLP) has drawn investor attention after its recent share moves, with the stock closing at US$44.37. That price appears alongside mixed recent returns and a value score of 3. See our latest analysis for Global Partners. The recent pullback, with a 1-day share price return of 1.40% decline and a 7-day share price return of 4.42% decline, contrasts with a 90-day share price return of 3.98% and multi year total shareholder returns that remain strongly positive. This points to...

Kennametal (KMT) is back on investors’ radar after its consensus EPS estimate for the current year moved 56.8% higher in the past 3 months, alongside an upgrade to Zacks Rank #1. See our latest analysis for Kennametal. The share price has moved to US$36.08 after a 25.93% 90 day share price return. The 1 year total shareholder return of 74.83% contrasts with a recent 10.43% 1 month share price decline, suggesting that momentum has cooled after a strong run. If this kind of swing in sentiment...

On March 23, Sensient Food Colors, a division of Sensient Technologies, marked the start of “Project Prism,” a major expansion of its largest natural color plant in St. Louis, Missouri, as part of a planned US$250 million program to grow capacity, supply chain and workforce. This expansion underlines how Sensient is committing significant long-term capital to meet rising demand for natural food colors as brands move away from artificial additives. Next, we’ll examine how Project Prism’s...

In March 2026, Newmark Group, Inc. was awarded the exclusive leasing, property management and project management assignment for a 66-building, 4.2 million-square-foot office and flex portfolio across key Suburban Philadelphia submarkets including Wayne, Malvern, Exton and Horsham. This large, court-receiver-controlled mandate underscores Newmark’s role in higher-quality, flex-oriented suburban assets where occupancy is comparatively strong and operational improvement is a core focus. Next,...

Arcellx (ACLX) has drawn attention after fresh performance data on its lead cancer immunotherapies prompted investors to reassess both the company’s clinical pipeline and its recent share price strength over the past 3 months. See our latest analysis for Arcellx. Over the past year Arcellx’s share price return of 80.88% year to date and 80.14% over 90 days, compared with a 74.65% one year total shareholder return and 290.09% three year total shareholder return, points to strong momentum...

What Gevo’s North Dakota expansion announcement means for the stock Gevo (GEVO) has attracted fresh attention after outlining plans to potentially add a second low carbon ethanol plant at its North Dakota site. This would more than double the current nameplate capacity. See our latest analysis for Gevo. The expansion news arrives after a strong run in the shares, with a 30 day share price return of 38.46% and a year to date share price return of 22.33%, while the 1 year total shareholder...

Cousins Properties recently announced that it executed a long-term lease with Oracle for 116,000 square feet at its Neuhoff mixed-use development in Nashville, where the office, retail, and residential components are already substantially leased. This agreement brings a prominent technology tenant into Neuhoff, underscoring tenant interest in Cousins’ Sun Belt mixed-use assets and the appeal of its Nashville footprint. We’ll now explore how landing Oracle as a long-term Neuhoff tenant may...